SCHEMBL862785

SCHEMBL862785

Cc1cc2cc(C)n(C)c2cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
HPGD P15428 6/20 0.39
KDM4E B2RXH2 5/20 0.39
GLA P06280 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 9/20 0.39
KMT2A Q03164 9/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 5/20 0.38
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2C19 P33261 3/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
BRPF1 P55201 1/20 0.37
ALOX15 P16050 5/20 0.37
PABPC1 P11940 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17427791 0.87 MEN1 (0.42) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL8944546 0.76 GPR35 (0.55) ALDH1A1HPGDKDM4ESMN1; SMN2MEN1
SCHEMBL11719401 0.76 MEN1 (0.40) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL21166602 0.76 MEN1 (0.37) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL18177589 0.75 MEN1 (0.39) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL24188520 0.73 KDM4E (0.35) ALDH1A1HPGDKDM4EGLASMN1; SMN2
SCHEMBL5039837 0.72 CASP1 (0.38) ALDH1A1HPGDKDM4ESMN1; SMN2MEN1
SCHEMBL12278050 0.72 MEN1 (0.37) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL12277986 0.72 MEN1 (0.37) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL5985980 0.71 MAPT (0.57) ALDH1A1HPGDKDM4ESMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160372675-A1 MACROMOLECULAR COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-12-22 US disclosed
US-9472763-B2 Macromolecular compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-18 US disclosed
US-20160152639-A1 POLYMERIC COMPOUND AND ELECTRONIC ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-02 US disclosed
US-9290510-B2 Polymeric compound and electronic element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-22 US disclosed
US-9209404-B2 Macromolecular compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-12-08 US disclosed
US-9006714-B2 Photovoltaic device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-04-14 US disclosed
US-8772763-B2 Photovoltaic cell SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-07-08 US disclosed
US-20140020760-A1 METHOD OF PRODUCING ORGANIC PHOTOELECTRIC CONVERSION DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-23 US disclosed
US-20120217448-A1 MACROMOLECULAR COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-30 US disclosed
US-20120205596-A1 MACROMOLECULAR COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-16 US disclosed
US-20120205593-A1 POLYMERIC COMPOUND AND ELECTRONIC ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-16 US disclosed
US-20120205644-A1 PHOTOVOLTAIC CELL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-16 US disclosed
US-20120205641-A1 PHOTOVOLTAIC CELL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-16 US disclosed
US-8142908-B2 Polymer light-emitting material comprising a conjugated polymer and compound exhibiting light emission from the triplet excited state and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-27 US disclosed
US-20120008068-A1 POLYMER COMPOUND AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-12 US disclosed
US-20070051922-A1 Polymer light-emitting material and polymer light-emitting device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-08 US disclosed
US-20070040164-A1 Polymer complex compound and polymer light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160372675-A1 MACROMOLECULAR COMPOUND EXOSC4, TRPC6, MRPS22 ALDH1A1 3653/4885HPGD 4858/4885KDM4E 2826/4885
US-20120205593-A1 POLYMERIC COMPOUND AND ELECTRONIC ELEMENT ARPC2, AXIN2, EMC2 ALDH1A1 1268/4885HPGD 2797/4885KDM4E 1757/4885
US-20120205596-A1 MACROMOLECULAR COMPOUND EXOSC4, TRPC6, MRPS22 ALDH1A1 3653/4885HPGD 4858/4885KDM4E 2826/4885
US-20160152639-A1 POLYMERIC COMPOUND AND ELECTRONIC ELEMENT ARPC2, AXIN2, EMC2 ALDH1A1 1314/4885HPGD 2847/4885KDM4E 1742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.